Decreasing stearoyl-CoA desaturase-1 expression inhibits β-catenin signaling in breast cancer cells

Cancer Science

Volumn 104, Issue 1, 2013, Pages 36-42

  Mauvoisin, Daniel ^a   Charfi, Cyndia ^a   Lounis, Amine M ^a   Rassart, Eric ^a   Mounier, Catherine ^a  

^a UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; MITOGEN ACTIVATED PROTEIN KINASE; OXYGENASE; STEAROYL COA DESATURASE 1; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CANCER CELL MDA MB 231; CELL CYCLE; CELL LINE; CELL PROLIFERATION; CELL STRAIN MCF 7; CELL VIABILITY; ENZYME INHIBITION; EPITHELIAL MESENCHYMAL TRANSITION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS;

BETA CATENIN; BREAST NEOPLASMS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; ENDOPLASMIC RETICULUM; EPITHELIAL-MESENCHYMAL TRANSITION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FATTY ACIDS, MONOUNSATURATED; FEMALE; GLYCOGEN SYNTHASE KINASES; HUMANS; MCF-7 CELLS; NEOPLASM INVASIVENESS; PHOSPHORYLATION; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STEAROYL-COA DESATURASE;

EID: 84872262047     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.12032     Document Type: Article

References (47)

1. Stephenson GD, Rose DP. Breast cancer and obesity: an update. Nutr Cancer 2003; 45: 1-16.
2. Roberts R, Hodson L, Dennis AL et al. Markers of de novo lipogenesis in adipose tissue: associations with small adipocytes and insulin sensitivity in humans. Diabetologia 2009; 52: 882-90.
3. Caron-Jobin M, Mauvoisin D, Michaud A et al. Stearic acid content of abdominal adipose tissues in obese women. Nutrition and Diabetes 2012; 2: e23.
4. Enoch HG, Catala A, Strittmatter P. Mechanism of rat liver microsomal stearyl-CoA desaturase Studies of the substrate specificity, enzyme-substrate interactions, and the function of lipid. J Biol Chem 1976; 251: 5095-103.
5. Ruggieri S, Roblin R, Black PH. Lipids of whole cells and plasma membrane fractions from Balb/c3T3, SV3T3, and concanavalin A-selected revertant cells. J Lipid Res 1979; 20: 760-71.
6. Bougnoux P, Chajes V, Lanson M et al. Prognostic significance of tumor phosphatidylcholine stearic acid level in breast carcinoma. Breast Cancer Res Treat 1992; 20: 185-94.
7. Williams CM, Maunder K. Fatty acid compositions of inositol and choline phospholipids of breast tumours and normal breast tissue. Eur J Clin Nutr 1993; 47: 260-7.
8. Scaglia N, Caviglia JM, Igal RA. High stearoyl-CoA desaturase protein and activity levels in simian virus 40 transformed-human lung fibroblasts. Biochim Biophys Acta 2005; 1687: 141-51.
9. Scaglia N, Chisholm JW, Igal RA. Inhibition of stearoylCoA desaturase-1 inactivates acetyl-CoA carboxylase and impairs proliferation in cancer cells: role of AMPK. PLoS ONE 2009; 4: e6812.
10. Igal RA. Stearoyl-CoA desaturase-1: a novel key player in the mechanisms of cell proliferation, programmed cell death and transformation to cancer. Carcinogenesis 2010; 31: 1509-15.
11. Chajes V, Hulten K, Van Kappel AL et al. Fatty-acid composition in serum phospholipids and risk of breast cancer: an incident case-control study in Sweden. Int J Cancer 1999; 83: 585-90.
12. Chajes V, Thiebaut AC, Rotival M et al. Association between serum trans-monounsaturated fatty acids and breast cancer risk in the E3N-EPIC Study. Am J Epidemiol 2008; 167: 1312-20.
13. Pala V, Krogh V, Muti P et al. Erythrocyte membrane fatty acids and subsequent breast cancer: a prospective Italian study. J Natl Cancer Inst 2001; 93: 1088-95.
14. Zureik M, Ducimetiere P, Warnet JM, Orssaud G. Fatty acid proportions in cholesterol esters and risk of premature death from cancer in middle aged French men. BMJ 1995; 311: 1251-4.
15. Petrek JA, Hudgins LC, Ho M, Bajorunas DR, Hirsch J. Fatty acid composition of adipose tissue, an indication of dietary fatty acids, and breast cancer prognosis. J Clin Oncol 1997; 15: 1377-84.
16. Zhu ZR, Agren J, Mannisto S et al. Fatty acid composition of breast adipose tissue in breast cancer patients and in patients with benign breast disease. Nutr Cancer 1995; 24: 151-60.
17. Simonsen NR, Fernandez-Crehuet NJ, Martin-Moreno JM et al. Tissue stores of individual monounsaturated fatty acids and breast cancer: the EURAMIC study. European Community Multicenter Study on Antioxidants, Myocardial Infarction, and Breast Cancer. Am J Clin Nutr 1998; 68: 134-41.
18. Yilmaz M, Christofori G, Lehembre F. Distinct mechanisms of tumor invasion and metastasis. Trends Mol Med 2007; 13: 535-41.
19. Schmalhofer O, Brabletz S, Brabletz T. E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer. Cancer Metastasis Rev 2009; 28: 151-66.
20. Wheelock MJ, Johnson KR. Cadherins as modulators of cellular phenotype. Annu Rev Cell Dev Biol 2003; 19: 207-35.
21. Amit S, Hatzubai A, Birman Y et al. Axin-mediated CKI phosphorylation of beta-catenin at Ser 45: a molecular switch for the Wnt pathway. Genes Dev 2002; 16: 1066-76.
22. Behrens J, Jerchow BA, Wurtele M et al. Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta. Science 1998; 280: 596-9.
23. Pinson KI, Brennan J, Monkley S, Avery BJ, Skarnes WC. An LDL-receptor-related protein mediates Wnt signalling in mice. Nature 2000; 407: 535-8.
24. Korinek V, Barker N, Morin PJ et al. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science 1997; 275: 1784-7.
25. Albanese C, Johnson J, Watanabe G et al. Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J Biol Chem 1995; 270: 23589-97.
26. Lavoie JN, L'Allemain G, Brunet A, Muller R, Pouyssegur J. Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J Biol Chem 1996; 271: 20608-16.
27. Liang J, Slingerland JM. Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression. Cell Cycle 2003; 2: 339-45.
28. Diehl JA, Cheng M, Roussel MF, Sherr CJ. Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev 1998; 12: 3499-511.
29. Scaglia N, Igal RA. Inhibition of Stearoyl-CoA Desaturase 1 expression in human lung adenocarcinoma cells impairs tumorigenesis. Int J Oncol 2008; 33: 839-50.
30. Gilles C, Polette M, Mestdagt M et al. Transactivation of vimentin by beta-catenin in human breast cancer cells. Cancer Res 2003; 63: 2658-64.
31. Aberle H, Bauer A, Stappert J, Kispert A, Kemler R. Beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J 1997; 16: 3797-804.
32. Yan D, Avtanski D, Saxena NK, Sharma D. Leptin-induced epithelial-mesenchymal transition in breast cancer cells requires beta-catenin activation via Akt/GSK3- and MTA1/Wnt1 protein-dependent pathways. J Biol Chem 2012; 287: 8598-612.
33. Yamashita T, Honda M, Takatori H et al. Activation of lipogenic pathway correlates with cell proliferation and poor prognosis in hepatocellular carcinoma. J Hepatol 2009; 50: 100-10.
34. Morgan-Lappe SE, Tucker LA, Huang X et al. Identification of Ras-related nuclear protein, targeting protein for xenopus kinesin-like protein 2, and stearoyl-CoA desaturase 1 as promising cancer targets from an RNAi-based screen. Cancer Res 2007; 67: 4390-8.
35. Mason P, Liang B, Li L et al. SCD1 Inhibition causes cancer cell death by depleting mono-unsaturated fatty acids. PLoS ONE 2012; 7: e33823.
36. Hess D, Igal RA. Genistein downregulates de novo lipid synthesis and impairs cell proliferation in human lung cancer cells. Exp Biol Med (Maywood) 2011; 236: 707-13.
37. Paton CM, Ntambi JM. Loss of stearoyl-CoA desaturase activity leads to free cholesterol synthesis through increased Xbp-1 splicing. Am J Physiol Endocrinol Metab 2010; 299: E1066-75.
38. Fritz V, Benfodda Z, Rodier G et al. Abrogation of de novo lipogenesis by stearoyl-CoA desaturase 1 inhibition interferes with oncogenic signaling and blocks prostate cancer progression in mice. Mol Cancer Ther 2010; 9: 1740-54.
39. Roongta UV, Pabalan JG, Wang X et al. Cancer cell dependence on unsaturated fatty acids implicates stearoyl-CoA desaturase as a target for cancer therapy. Mol Cancer Res 2011; 9: 1551-61.
40. Hess D, Chisholm JW, Igal RA. Inhibition of stearoylCoA desaturase activity blocks cell cycle progression and induces programmed cell death in lung cancer cells. PLoS ONE 2010; 5: e11394.
41. Prasad CP, Rath G, Mathur S, Bhatnagar D, Parshad R, Ralhan R. Expression analysis of E-cadherin, Slug and GSK3beta in invasive ductal carcinoma of breast. BMC Cancer 2009; 9: 325.
42. Kim K, Lu Z, Hay ED. Direct evidence for a role of beta-catenin/LEF-1 signaling pathway in induction of EMT. Cell Biol Int 2002; 26: 463-76.
43. Logullo AF, Nonogaki S, Pasini FS, Osorio CA, Soares FA, Brentani MM. Concomitant expression of epithelial-mesenchymal transition biomarkers in breast ductal carcinoma: association with progression. Oncol Rep 2010; 23: 313-20.
44. Lin SY, Xia W, Wang JC et al. Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression. Proc Natl Acad Sci USA 2000; 97: 4262-6.
45. Bjorklund P, Svedlund J, Olsson AK, Akerstrom G, Westin G. The internally truncated LRP5 receptor presents a therapeutic target in breast cancer. PLoS ONE 2009; 4: e4243.
46. Takada R, Satomi Y, Kurata T et al. Monounsaturated fatty acid modification of Wnt protein: its role in Wnt secretion. Dev Cell 2006; 11: 791-801.
47. De Wet JR, Wood KV, DeLuca M, Helinski DR, Subramani S. Firefly luciferase gene: structure and expression in mammalian cells. Mol Cell Biol 1987; 7: 725-37.